ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,724, issued on June 30, was assigned to Flow Neuroscience Inc. (Palo Alto, Calif.).
"Combination therapy for the treatment of depression" was invented by Daniel Mansson (Simrishamn, Sweden) and Erik Rehn (Enebyberg, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for treating depression and depression-related conditions by combining administration of pharmacologic agents and neuromodulation induced by transcranial electrical stimulation."
The patent was filed on Sept. 19, 2024, under Application No. 18/890,394.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph...